共 50 条
- [35] THE SPECIFIC BINDING OF SERUM IGA FROM IGA NEPHROPATHY PATIENTS TO HUMAN MESANGIAL CELLS IS INHIBITED AFTER CELL PRETREATMENT WITH NEUTROPHIL ELASTASE JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 742 - 742
- [36] Neuraminidase treatment abrogates the binding abnormality of IgA1 from IgA nephropathy patients and the differential charge distribution of its α-heavy chains NEPHRON, 2001, 89 (04): : 422 - 425
- [37] Cell-Surface Glycoprofiling of IgA1-Secreting Cells From Patients With IgA Nephropathy Reveals Subpopulations With Differential Cytokine Responses and Capacity to Produce Galactose-Deficient IgA1 JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 781 - 781
- [38] Serum IgA1-IgG-Containing Immune Complexes From Patients With IgA Nephropathy Activate Cultured Human Mesangial Cells and Associate With Cellular Integrin β1 JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 781 - 781
- [40] The Combined Role of Galactose-Deficient IgA1 and Streptococcal IgA-Binding M Protein in Inducing IL-6 and C3 Secretion from Human Mesangial Cells: Implications for IgA Nephropathy JOURNAL OF IMMUNOLOGY, 2014, 193 (01): : 317 - 326